Profil
Pierre Arnaud is currently the Chief Executive Officer at Galia Gestion SAS since 2021.
He previously worked as a Non-Executive Director at Antabio SAS.
Postes actifs de Pierre Arnaud
| Sociétés | Poste | Début |
|---|---|---|
Galia Gestion SAS
 Galia Gestion SAS Investment ManagersFinance Galia Gestion SAS (Galia Gestion) is a regional French private equity firm which was created in 2002 to provide capital for small- to medium-sized businesses in the Aquitaine, Poitou-Charentes, Limousin and Midi-Pyrénées regions. Located in Bordeaux, Galia Gestion manages the Galia Investissements 1 and Expanso Investissements FCPRs, the Galia PME 1, 2, 3, 4, 5, 6, 7 and 8 FIPs, Galia Poitou Charentes FIP and Galia Venture, a venture capital firm, for institutional investors. | Directeur Général | 01/05/2021 |
Anciens postes connus de Pierre Arnaud
| Sociétés | Poste | Fin |
|---|---|---|
Antabio SAS
 Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Galia Gestion SAS
Galia Gestion SAS Investment ManagersFinance Galia Gestion SAS (Galia Gestion) is a regional French private equity firm which was created in 2002 to provide capital for small- to medium-sized businesses in the Aquitaine, Poitou-Charentes, Limousin and Midi-Pyrénées regions. Located in Bordeaux, Galia Gestion manages the Galia Investissements 1 and Expanso Investissements FCPRs, the Galia PME 1, 2, 3, 4, 5, 6, 7 and 8 FIPs, Galia Poitou Charentes FIP and Galia Venture, a venture capital firm, for institutional investors. | Finance |
Antabio SAS
Antabio SAS Pharmaceuticals: MajorHealth Technology Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France. | Health Technology |
